Bio-Path Holdings Inc (BPTH)
2.10
+0.17
(+8.81%)
USD |
NASDAQ |
May 31, 16:00
2.10
0.00 (0.00%)
After-Hours: 20:00
Bio-Path Holdings Net Income (Quarterly): -3.157M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -3.157M |
December 31, 2023 | -3.372M |
September 30, 2023 | -3.199M |
June 30, 2023 | -4.234M |
March 31, 2023 | -5.273M |
December 31, 2022 | -3.966M |
September 30, 2022 | -3.535M |
June 30, 2022 | -3.008M |
March 31, 2022 | -3.359M |
December 31, 2021 | -4.116M |
September 30, 2021 | -2.069M |
June 30, 2021 | -1.808M |
March 31, 2021 | -2.447M |
December 31, 2020 | -2.55M |
September 30, 2020 | -2.968M |
June 30, 2020 | -2.04M |
March 31, 2020 | -3.324M |
December 31, 2019 | -2.389M |
September 30, 2019 | -2.242M |
June 30, 2019 | -2.456M |
March 31, 2019 | -1.512M |
December 31, 2018 | -1.909M |
September 30, 2018 | -3.081M |
June 30, 2018 | -1.677M |
March 31, 2018 | -1.916M |
Date | Value |
---|---|
December 31, 2017 | -2.167M |
September 30, 2017 | -2.474M |
June 30, 2017 | -1.985M |
March 31, 2017 | -0.397M |
December 31, 2016 | -1.371M |
September 30, 2016 | -1.57M |
June 30, 2016 | -1.942M |
March 31, 2016 | -1.867M |
December 31, 2015 | -1.459M |
September 30, 2015 | -1.508M |
June 30, 2015 | -1.126M |
March 31, 2015 | -1.375M |
December 31, 2014 | -1.597M |
September 30, 2014 | -1.148M |
June 30, 2014 | -1.269M |
March 31, 2014 | -0.5049M |
December 31, 2013 | -0.7896M |
September 30, 2013 | -1.393M |
June 30, 2013 | -0.4272M |
March 31, 2013 | -0.656M |
December 31, 2012 | -0.4319M |
September 30, 2012 | -0.8406M |
June 30, 2012 | -0.7878M |
March 31, 2012 | -0.5222M |
December 31, 2011 | -0.8041M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-5.273M
Minimum
Mar 2023
-1.808M
Maximum
Jun 2021
-3.076M
Average
-3.082M
Median
Net Income (Quarterly) Benchmarks
INVO Bioscience Inc | -1.596M |
Perspective Therapeutics Inc | -12.28M |
EyePoint Pharmaceuticals Inc | -29.28M |
Palatin Technologies Inc | -8.436M |
Lumos Pharma Inc | -10.44M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 3.695M |
EPS Diluted (Quarterly) | -4.88 |
Enterprise Value | 3.29M |
Earnings Yield | -1.24K% |
Normalized Earnings Yield | -19059.92 |